Research Article | | Peer-Reviewed

Factors Associated with Complete HPV Vaccination Among Girls Aged 11-13 Years in Diakhao Health District in 2021

Received: 19 January 2025     Accepted: 13 February 2025     Published: 29 May 2025
Views:       Downloads:
Abstract

Introduction: In 2021, (88.6%) of Senegal's 79 districts had not reached the full Human papillomavirus (HPV) vaccination coverage target of (90%). The Diakhao health district had full vaccination coverage of (10%) in the same year. This study aimed to identify factors associated with full vaccination coverage among girls aged 11-13 in Diakhao health district. Method: This was a descriptive and analytical study conducted in Diakhao health district among 228 custodial mothers of young girls aged 11-13 years. Data were collected using a questionnaire assessing the knowledge, attitudes, practices, and satisfaction of custodial mothers of young girls aged 11-13 years about HPV vaccination. Descriptive, bivariate analysis, and logistic regression were performed at 5% alpha. Results: The majority (74.12%) of mothers and guardians had heard of cervical cancer, and 81.58% had heard of HPV vaccination. According to the mothers and guardians of young girls, there was complete coverage (17.54%). According to the vaccination card, complete coverage was (15.79%). Factors associated with complete coverage were: the girl's schooling (ORa = 3.56 (1.12-11.29); having heard about cervical cancer vaccination (ORa = 0.09 (0.02, 0.32)]); rural residence (ORa = 0.13 (0.04-0. 44); agreement with vaccination for reasons of protection against certain communicable diseases (ORa = 8.95 (1.27-63.11) or reasons of vaccination of neighbors' children (ORa = 3.25 (1.24-8.55), satisfaction with counseling (ORa = 6.49 (1.63-25.8). Conclusion: Information to mothers or guardians of young girls is crucial to achieving the goal of full immunization coverage. It could be significantly improved by an acceleration plan focusing on interpersonal communication.

Published in World Journal of Public Health (Volume 10, Issue 2)
DOI 10.11648/j.wjph.20251002.16
Page(s) 129-139
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2025. Published by Science Publishing Group

Keywords

Cervical Cancer, HPV Vaccination, Girls, Diakhao, Senegal

References
[1] Kafuruki L, PF Rambau, Massinde A, Masalu N. Prevalence and predictors of cervical intraepithelial neoplasia among HIV infected women at Bugando Medical Centre, MwanzaTanzania. Infectious Agents and Cancer. 2013 Nov; 8(1): 45-47.
[2] Torre LA, Bray F, Siegel RL, J Ferlay, J LortetTieulent, Jemal A. Worldwide cancer statistics. CA Cancer J Clin. 2015 Mars; 65(2): 87-108.
[3] World Health Organisation. Ten threats to global health in 2019. World Health Organisation Marblehead. 2019.
[4] Lamontagne DS, Barge S, Le NT, Mugisha E, Penny ME, Gandhi S et al. Human papillomavirus vaccine delivery strategies that achieved high coverage in low- and middleincome countries. Bull World Health Organisation. 2011 Nov; 89(11): 821-830.
[5] Institute for Public Health Research. Vaccination against papillomavirus in France: current state of knowledge and actions to improve vaccination coverage as part of action 125 of the Cancer Plan. France (ITMO Santé Publique). 2019; p10-11.
[6] Heleen Vermandere, Violet Naanyu, Hillary Mabeya, Davy Vanden Broeck, Kristien Michielsen, Olivier Degomme. Determinants of acceptance and subsequent uptake of the HPV vaccine in a cohort in Eldoret, Kenya. Plos one. 2014 Oct; 9(10): e109353.
[7] Watson-Jones D, Tomlin K, Remes P, Baisley K, Ponsiano Ret al. Reasons for Receiving or Not Receiving HPV Vaccination in Primary Schoolgirls in Tanzania: a case control study (2012). Plos one. 2012; 7(10): e45231.
[8] Ministry of Health and Social Action (MSAS). Guidance for vaccination against Human Papillomavirus Infections (HPV). Sénégal (MSAS). 2018; p3-4.
[9] World Health Organisation (WHO). Human papillomavirus (HPV) and cervical cancer. Génève, World Health Organisation.
[10] World Health Organisation (WHO). A future without cervical cancer: for the first time, the world commits to eliminating a cancer. Génève, World Health Organisation.
[11] World Health Organisation (WHO). Controlling non-communicable diseases during and after the COVID-19 pandemic. Génève, World Health Organisation. Accessed: Nov. 04, 2022. [Online]. Available:
[12] Ministry of Health and Social Action (MSAS). Newsletter from the Immunization Division against Covid-19. Sénégal (MSAS). 2020; vol. 7: pp. 1-10.
[13] J. A. D. Tine, and al. Cervical cancer prevention in the Kédougou region. End of training thesis. 2019.
[14] R. Andersen and J. F. Newman. Societal and individual determinants of medical care utilization in the United States. Milbank Q. 2005; vol. 83, no. 4: pp. 1-28.
[15] M. Ndiaye, B. Sawadogo, I. Sonko, I. O. Ba, and M. M. M. Leye. Factors associated with human papillomavirus vaccination in a context of scale-up in Senegal: a case-control survey of parents. Pan Afr. Med. J. 2021; vol. 39,
[16] National Agency for Statistics and Demography (ANSD/SRS). Regional Economic and Social Situation 2013. Fatick, Regional Statistics and Demography Serv. 2015; p. 107.
[17] K. A. Rabiu, T. G. Alausa, F. M. Akinlusi, N. O. Davies, K. A. Shittu, and O. I. Akinola. Parental acceptance of human papillomavirus vaccination for adolescent girls in Lagos, Nigeria. J. Fam. Med. Prim. Care. Jan 2020; vol. 9, no. 6, pp. 2950-2957,
[18] S. Feng, X. Xu, Y. Jin, and X. Yao. Women’s knowledge of human papillomavirus (HPV) and their attitudes toward HPV vaccine: Preparing for HPV vaccination in China. Asia-Pacific J. Public Heal. 2012; vol. 24, no. 3, pp. 522-531,
[19] A. O. Almobarak, A. A. Elbadawi, W. M. Elmadhoun, M. H. Elhoweris, and M. H. Ahmed. Knowledge, attitudes and practices of sudanese women regarding the Pap smear test and cervical cancer. Asian Pacific J. Cancer Prev. 2016; vol. 17, no. 2, pp. 625-630,
[20] M. Ganczak, B. Owsianka, and M. Korzeń. Factors that predict parentalwillingness to have their children vaccinated against HPV in a country with low HPV vaccination coverage. Int. J. Environ. Res. Public Health. 2018; vol. 15, no. 4,
[21] A. L. Swiecki-Sikora, K. A. Henry, and D. Kepka. HPV Vaccination Coverage Among US Teens Across the Rural-Urban Continuum. J. Rural Heal. 2019; vol. 35, no. 4, pp. 506-517,
[22] D. JHT, S. SL, B. DA, R. HP, and C. MS. Patient and clinician factors associated with uptake of the human papillomavirus (HPV) vaccine among adolescent patients of a primary care network. Vaccine. Jun. 2021; vol. 39, no. 26, pp. 3528-3535,
[23] M. De, World Health Organisation, Vaccination Department de. Vaccines and biological products. Génève, World Health Organisation.
[24] Ministry of Health and Social Action (MSAS). Training guide for vaccination against Human Papillomavirus (HPV) infections: Training guide_HPV_valid 08082018_VF. MSAS. Mai 2018.
[25] C. M. Egoavil et al. Trends of adverse events following immunization (AEFI) reports of human papillomavirus vaccine in the valencian community—Spain (2008-2018). Vaccines. 2020; vol. 8, no. 1, pp. 1-12,
[26] X. C. Liu, C. A. Bell, K. A. Simmonds, L. W. Svenson, and M. L. Russell. Adverse events following HPV vaccination, Alberta 2006-2014. Vaccine. 2016; vol. 34, no. 15, pp. 1800-1805,
[27] A. Faye, S. Ndiaye, K. Niang, M. Ndiaye, A. Tal-Dia. Determinants of Vaccination Coverage Against Human Papillomavirus in 10-year-old Girls in 2016 in Rural Senegal. Sci. J. Public Heal. 2017; vol. 5, no. 6, p. 464,
[28] A Phillips, Megan Hickie, J. Totterdell and al. Adverse events following HPV vaccination: 11 years of surveillance in Australia. Vaccine. 2020; vol. 38, no. 38, pp. 6038-6046,
[29] M. Guay, P. Clément, A. Hamid, J. Lemaire, C. Sauvageau, E. Dubé, C. Vanier, N. Boulianne, M. Landry. Evaluation of the implementation of the Human Papillomavirus (HPV) vaccination program in adolescent girls in Québec. 2012.
[30] H. A. L. Id. Vaccination against human papillomavirus infections: survey of parents of adolescent enrolled in junior schools and Meuse senior high schools on reasons for taking up and not taking up vaccination, and identification. 2018.
[31] High Council for Public Health. Opinions and reports: Vaccination against human papillomavirus infections. High Council for Public Health. 2014 [Online]. Available:
[32] T. Alene, A. Atnafu, Z. A. Mekonnen, and A. Minyihun. Acceptance of human papillomavirus vaccination and associated factors among parents of daughters in gondar town, northwest Ethiopia. Cancer Manag. Res. 2020; vol. 12, pp. 8519-8526,
Cite This Article
  • APA Style

    Diongue, F. B., Touré, A., Bassoum, O., Diallo, A., Sow, A., et al. (2025). Factors Associated with Complete HPV Vaccination Among Girls Aged 11-13 Years in Diakhao Health District in 2021. World Journal of Public Health, 10(2), 129-139. https://doi.org/10.11648/j.wjph.20251002.16

    Copy | Download

    ACS Style

    Diongue, F. B.; Touré, A.; Bassoum, O.; Diallo, A.; Sow, A., et al. Factors Associated with Complete HPV Vaccination Among Girls Aged 11-13 Years in Diakhao Health District in 2021. World J. Public Health 2025, 10(2), 129-139. doi: 10.11648/j.wjph.20251002.16

    Copy | Download

    AMA Style

    Diongue FB, Touré A, Bassoum O, Diallo A, Sow A, et al. Factors Associated with Complete HPV Vaccination Among Girls Aged 11-13 Years in Diakhao Health District in 2021. World J Public Health. 2025;10(2):129-139. doi: 10.11648/j.wjph.20251002.16

    Copy | Download

  • @article{10.11648/j.wjph.20251002.16,
      author = {Fatoumata Binetou Diongue and Ablaye Touré and Oumar Bassoum and Amadou Diallo and Adama Sow and Ibrahima Ndiaye and Jean Augustin Diégane Tine and Ndeye Marème Sougou and Maty Diagne Camara and Lamine Gaye and Mayacine Diongue and Mamadou MM Leye and Ibrahima Seck and Adama Faye},
      title = {Factors Associated with Complete HPV Vaccination Among Girls Aged 11-13 Years in Diakhao Health District in 2021
    },
      journal = {World Journal of Public Health},
      volume = {10},
      number = {2},
      pages = {129-139},
      doi = {10.11648/j.wjph.20251002.16},
      url = {https://doi.org/10.11648/j.wjph.20251002.16},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.wjph.20251002.16},
      abstract = {Introduction: In 2021, (88.6%) of Senegal's 79 districts had not reached the full Human papillomavirus (HPV) vaccination coverage target of (90%). The Diakhao health district had full vaccination coverage of (10%) in the same year. This study aimed to identify factors associated with full vaccination coverage among girls aged 11-13 in Diakhao health district. Method: This was a descriptive and analytical study conducted in Diakhao health district among 228 custodial mothers of young girls aged 11-13 years. Data were collected using a questionnaire assessing the knowledge, attitudes, practices, and satisfaction of custodial mothers of young girls aged 11-13 years about HPV vaccination. Descriptive, bivariate analysis, and logistic regression were performed at 5% alpha. Results: The majority (74.12%) of mothers and guardians had heard of cervical cancer, and 81.58% had heard of HPV vaccination. According to the mothers and guardians of young girls, there was complete coverage (17.54%). According to the vaccination card, complete coverage was (15.79%). Factors associated with complete coverage were: the girl's schooling (ORa = 3.56 (1.12-11.29); having heard about cervical cancer vaccination (ORa = 0.09 (0.02, 0.32)]); rural residence (ORa = 0.13 (0.04-0. 44); agreement with vaccination for reasons of protection against certain communicable diseases (ORa = 8.95 (1.27-63.11) or reasons of vaccination of neighbors' children (ORa = 3.25 (1.24-8.55), satisfaction with counseling (ORa = 6.49 (1.63-25.8). Conclusion: Information to mothers or guardians of young girls is crucial to achieving the goal of full immunization coverage. It could be significantly improved by an acceleration plan focusing on interpersonal communication.
    },
     year = {2025}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Factors Associated with Complete HPV Vaccination Among Girls Aged 11-13 Years in Diakhao Health District in 2021
    
    AU  - Fatoumata Binetou Diongue
    AU  - Ablaye Touré
    AU  - Oumar Bassoum
    AU  - Amadou Diallo
    AU  - Adama Sow
    AU  - Ibrahima Ndiaye
    AU  - Jean Augustin Diégane Tine
    AU  - Ndeye Marème Sougou
    AU  - Maty Diagne Camara
    AU  - Lamine Gaye
    AU  - Mayacine Diongue
    AU  - Mamadou MM Leye
    AU  - Ibrahima Seck
    AU  - Adama Faye
    Y1  - 2025/05/29
    PY  - 2025
    N1  - https://doi.org/10.11648/j.wjph.20251002.16
    DO  - 10.11648/j.wjph.20251002.16
    T2  - World Journal of Public Health
    JF  - World Journal of Public Health
    JO  - World Journal of Public Health
    SP  - 129
    EP  - 139
    PB  - Science Publishing Group
    SN  - 2637-6059
    UR  - https://doi.org/10.11648/j.wjph.20251002.16
    AB  - Introduction: In 2021, (88.6%) of Senegal's 79 districts had not reached the full Human papillomavirus (HPV) vaccination coverage target of (90%). The Diakhao health district had full vaccination coverage of (10%) in the same year. This study aimed to identify factors associated with full vaccination coverage among girls aged 11-13 in Diakhao health district. Method: This was a descriptive and analytical study conducted in Diakhao health district among 228 custodial mothers of young girls aged 11-13 years. Data were collected using a questionnaire assessing the knowledge, attitudes, practices, and satisfaction of custodial mothers of young girls aged 11-13 years about HPV vaccination. Descriptive, bivariate analysis, and logistic regression were performed at 5% alpha. Results: The majority (74.12%) of mothers and guardians had heard of cervical cancer, and 81.58% had heard of HPV vaccination. According to the mothers and guardians of young girls, there was complete coverage (17.54%). According to the vaccination card, complete coverage was (15.79%). Factors associated with complete coverage were: the girl's schooling (ORa = 3.56 (1.12-11.29); having heard about cervical cancer vaccination (ORa = 0.09 (0.02, 0.32)]); rural residence (ORa = 0.13 (0.04-0. 44); agreement with vaccination for reasons of protection against certain communicable diseases (ORa = 8.95 (1.27-63.11) or reasons of vaccination of neighbors' children (ORa = 3.25 (1.24-8.55), satisfaction with counseling (ORa = 6.49 (1.63-25.8). Conclusion: Information to mothers or guardians of young girls is crucial to achieving the goal of full immunization coverage. It could be significantly improved by an acceleration plan focusing on interpersonal communication.
    
    VL  - 10
    IS  - 2
    ER  - 

    Copy | Download

Author Information
  • Sections